Search research articles
Contact Us
Filters
Showing results (261-270 of 627) with videos related to
Page
of 63
Sort By:
Kidney International Reports
|
February 12, 2024
Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A <i>Post Hoc</i> Analysis of CREDENCE Trial
Akihiko Koshino, Brendon L Neuen, Megumi Oshima, et al.
The American Journal of Cardiology
|
February 22, 2005
Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial)
Manesh R Patel, Kenneth W Mahaffey, Paul W Armstrong, et al.
Stroke
|
April 29, 2006
Statin use and sex-specific stroke outcomes in patients with vascular disease
Cheryl D Bushnell, Jeffrey Griffin, L Kristin Newby, et al.
Journal of the American College of Cardiology
|
September 9, 2017
Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry
Justin B Echouffo-Tcheugui, Peter Shrader, Laine Thomas, et al.
American Heart Journal
|
September 29, 2014
Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Emily C O'Brien, DaJuanicia N Simon, Larry A Allen, et al.
Diabetes Care
|
July 29, 2025
Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis
Peter Rossing, George Bakris, Vlado Perkovic, et al.
Stroke
|
March 20, 1998
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries
J M Gebel, C A Sila, M A Sloan, et al.
American Heart Journal
|
June 20, 2017
Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)
Benjamin A Steinberg, Peter Shrader, Laine Thomas, et al.
Circulation. Cardiovascular Interventions
|
January 1, 2017
Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary Intervention
Neal N Sawlani, Robert A Harrington, Gregg W Stone, et al.
American Heart Journal
|
June 12, 2020
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)
Larry R Jackson, Sunghee Kim, Rosalia Blanco, et al.
Page
of 63
Search research articles
Search
Showing results (261-270 of 627) with videos related to
Sort By:
Page
of 63
Kidney International Reports
|
February 12, 2024
Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A <i>Post Hoc</i> Analysis of CREDENCE Trial
Akihiko Koshino, Brendon L Neuen, Megumi Oshima, et al.
The American Journal of Cardiology
|
February 22, 2005
Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial)
Manesh R Patel, Kenneth W Mahaffey, Paul W Armstrong, et al.
Stroke
|
April 29, 2006
Statin use and sex-specific stroke outcomes in patients with vascular disease
Cheryl D Bushnell, Jeffrey Griffin, L Kristin Newby, et al.
Journal of the American College of Cardiology
|
September 9, 2017
Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry
Justin B Echouffo-Tcheugui, Peter Shrader, Laine Thomas, et al.
American Heart Journal
|
September 29, 2014
Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
Emily C O'Brien, DaJuanicia N Simon, Larry A Allen, et al.
Diabetes Care
|
July 29, 2025
Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis
Peter Rossing, George Bakris, Vlado Perkovic, et al.
Stroke
|
March 20, 1998
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries
J M Gebel, C A Sila, M A Sloan, et al.
American Heart Journal
|
June 20, 2017
Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)
Benjamin A Steinberg, Peter Shrader, Laine Thomas, et al.
Circulation. Cardiovascular Interventions
|
January 1, 2017
Impact of Cerebrovascular Events Older Than One Year on Ischemic and Bleeding Outcomes With Cangrelor in Percutaneous Coronary Intervention
Neal N Sawlani, Robert A Harrington, Gregg W Stone, et al.
American Heart Journal
|
June 12, 2020
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)
Larry R Jackson, Sunghee Kim, Rosalia Blanco, et al.
Page
of 63